关注
Ali T. Taher
Ali T. Taher
Professor of Medicine, Hematology & Oncology, American University of Beirut Medical Center
在 aub.edu.lb 的电子邮件经过验证
标题
引用次数
引用次数
年份
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
KM Musallam, HM Tamim, T Richards, DR Spahn, FR Rosendaal, ...
The Lancet 378 (9800), 1396-1407, 2011
14012011
Thalassaemia
AT Taher, DJ Weatherall, MD Cappellini
The Lancet 391 (10116), 155-167, 2018
7402018
Guidelines for the management of transfusion dependent thalassaemia (TDT)
MD Cappellini, A Cohen, J Porter, A Taher, V Viprakasit
Thalassaemia International Federation, 2014
6672014
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
MD Cappellini, J Comin‐Colet, A de Francisco, A Dignass, W Doehner, ...
American journal of hematology 92 (10), 1068-1078, 2017
4982017
Iron deficiency anaemia revisited
MD Cappellini, KM Musallam, AT Taher
Journal of internal medicine 287 (2), 153-170, 2020
4932020
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
AT Taher, KM Musallam, M Karimi, A El-Beshlawy, K Belhoul, S Daar, ...
Blood, The Journal of the American Society of Hematology 115 (10), 1886-1892, 2010
4592010
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...
The Lancet Oncology 20 (10), e566-e581, 2019
4552019
Thalassemia intermedia: revisited
A Taher, H Isma'eel, MD Cappellini
Blood Cells, Molecules, and Diseases 37 (1), 12-20, 2006
4482006
Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran
A Taher, H Isma’eel, G Mehio, D Bignamini, A Kattamis, EA Rachmilewitz, ...
Thrombosis and haemostasis 96 (10), 488-491, 2006
4082006
Guidelines for the clinical management of thalassaemia
MD Cappellini, A Cohen, A Eleftheriou, A Piga, J Porter, A Taher
3452013
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
MD Cappellini, J Porter, A El-Beshlawy, CK Li, JF Seymour, M Elalfy, ...
haematologica 95 (4), 557, 2010
3452010
Iron overload in thalassemia: different organs at different rates
AT Taher, AN Saliba
Hematology 2014, the American Society of Hematology Education Program Book …, 2017
2922017
Guidelines for the management of non transfusion dependent thalassaemia (NTDT)
A Taher, E Vichinsky, K Musallam, MD Cappellini, V Viprakasit
2892014
How I treat transfusional iron overload
AV Hoffbrand, A Taher, MD Cappellini
Blood, The Journal of the American Society of Hematology 120 (18), 3657-3669, 2012
2742012
Optimal management of β thalassaemia intermedia
AT Taher, KM Musallam, MD Cappellini, DJ Weatherall
British journal of haematology 152 (5), 512-523, 2011
2702011
A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia
MD Cappellini, V Viprakasit, AT Taher, P Georgiev, KHM Kuo, T Coates, ...
New England Journal of Medicine 382 (13), 1219-1231, 2020
2612020
β-Thalassemias
AT Taher, KM Musallam, MD Cappellini
New England Journal of Medicine 384 (8), 727-743, 2021
2512021
Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia
KM Musallam, AT Taher, MD Cappellini, VG Sankaran
Blood, The Journal of the American Society of Hematology 121 (12), 2199-2212, 2013
2402013
Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia
R Haidar, H Mhaidli, AT Taher
European Spine Journal 19, 871-878, 2010
2372010
Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia
DJ Pennell, JB Porter, MD Cappellini, A El-Beshlawy, LL Chan, Y Aydinok, ...
Blood, The Journal of the American Society of Hematology 115 (12), 2364-2371, 2010
2362010
系统目前无法执行此操作,请稍后再试。
文章 1–20